A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology
出版年份 2021 全文链接
标题
A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology
作者
关键词
-
出版物
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-24
DOI
10.1007/s10557-021-07186-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efecto pronóstico diferencial de la diabetes mellitus tipo 2 en mujeres y varones con insuficiencia cardiaca y fracción de eyección conservada
- (2020) Patricia Palau et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Distinct Pathological Pathways in Patients With Heart Failure and Diabetes
- (2020) Jasper Tromp et al. JACC-Heart Failure
- Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
- (2020) Björn Pasternak et al. BMJ-British Medical Journal
- Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies
- (2020) A. Avogaro et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial
- (2020) Francesco Cosentino et al. CIRCULATION
- Heart Failure in Type 2 Diabetes Mellitus
- (2019) Helena C. Kenny et al. CIRCULATION RESEARCH
- Heart failure and type 2 diabetes: From CVOTs, with hope
- (2019) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- Long-term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines–Heart Failure Registry
- (2019) Boback Ziaeian et al. AMERICAN HEART JOURNAL
- SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules
- (2019) Antoine Daina et al. NUCLEIC ACIDS RESEARCH
- Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
- (2019) Tada Kunavisarut et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Class effects of SGLT2 inhibitors on cardiorenal outcomes
- (2019) Aaron Y. Kluger et al. Cardiovascular Diabetology
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophages from a type 1 diabetes mouse model present dysregulated Pl3K/AKT, ERK 1/2 and SAPK/JNK levels
- (2019) Fernando Henrique Galvão Tessaro et al. IMMUNOBIOLOGY
- Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors
- (2019) Muthiah Vaduganathan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy
- (2018) Fengbo Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Cardiomyocytes Sense Matrix Rigidity through a Combination of Muscle and Non-muscle Myosin Contractions
- (2018) Pragati Pandey et al. DEVELOPMENTAL CELL
- Inhibition of Epidermal Growth Factor Receptor Activation is Associated with Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes
- (2018) Zhilian Li et al. DIABETES
- Development of SGLT1 and SGLT2 inhibitors
- (2018) Timo Rieg et al. DIABETOLOGIA
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2018) Petar M. Seferović et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study
- (2018) Gian Paolo Fadini et al. DIABETES OBESITY & METABOLISM
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure
- (2017) Abhinav Sharma et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rap1B promotes VEGF-induced endothelial permeability and is required for dynamic regulation of the endothelial barrier
- (2017) Sribalaji Lakshmikanthan et al. JOURNAL OF CELL SCIENCE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- HMDB 4.0: the human metabolome database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Computational Molecular Networks and Network Pharmacology
- (2017) Kang Ning et al. Biomed Research International
- Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
- (2017) Jacob A. Udell et al. CIRCULATION
- Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
- (2016) Jagdeep S. S. Singh et al. Cardiovascular Diabetology
- Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK
- (2016) Eun-Jung Bak et al. CLINICAL NUTRITION
- Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
- (2016) Kesong Peng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Identification of new key genes for type 1 diabetes through construction and analysis of protein-protein interaction networks based on blood and pancreatic islet transcriptomes
- (2016) Nahid Safari-Alighiarloo et al. Journal of Diabetes
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- TAB3 involves in hepatic insulin resistance through activation of MAPK pathway
- (2015) Yun Zhao et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin II-triggered kinase signaling cascade in the central nervous system
- (2015) Anjana Bali et al. REVIEWS IN THE NEUROSCIENCES
- Role of AGEs-RAGE System in Cardiovascular Disease
- (2014) Kei Fukami et al. CURRENT PHARMACEUTICAL DESIGN
- Epidermal Growth Factor Receptor Inhibition Slows Progression of Diabetic Nephropathy in Association With a Decrease in Endoplasmic Reticulum Stress and an Increase in Autophagy
- (2014) Ming-Zhi Zhang et al. DIABETES
- Advanced glycation end products: role in pathology of diabetic cardiomyopathy
- (2013) Vijaya Lakshmi Bodiga et al. HEART FAILURE REVIEWS
- Palmitate induces reactive oxygen species production and β-cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling
- (2013) Yuichi Sato et al. Journal of Diabetes Investigation
- Enhanced myogenic constriction of mesenteric artery in heart failure relates to decreased smooth muscle cell caveolae numbers and altered AT1- and epidermal growth factor-receptor function
- (2009) Ying Xu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice
- (2008) S. Belmadani et al. DIABETES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started